Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Lopez Perez, Ramon [VerfasserIn]   i
 Münz, Franziska [VerfasserIn]   i
 Rühle, Alexander [VerfasserIn]   i
 Trinh, Thuy [VerfasserIn]   i
 Wuchter, Patrick [VerfasserIn]   i
 Debus, Jürgen [VerfasserIn]   i
 Saffrich, Rainer [VerfasserIn]   i
 Huber, Peter E. [VerfasserIn]   i
 Nicolay, Nils [VerfasserIn]   i
Titel:Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy
Verf.angabe:Ramon Lopez Perez, Franziska Münz, Denise Vidoni, Alexander Rühle, Thuy Trinh, Sonevisay Sisombath, Bingwen Zou, Patrick Wuchter, Jürgen Debus, Anca-Ligia Grosu, Rainer Saffrich, Peter E. Huber, Nils H. Nicolay
E-Jahr:2019
Jahr:13 August 2019
Illustrationen:Illustrationen
Fussnoten:Gesehen am 11.12.2019
Titel Quelle:Enthalten in: Stem cell research
Ort Quelle:Amsterdam [u.a.] : Elsevier, 2007
Jahr Quelle:2019
Band/Heft Quelle:40(2019) Artikel-Nummer 101536, Seite 1-11, 11 Seiten
ISSN Quelle:1876-7753
Abstract:Background - Mesenchymal stem cells (MSCs) participate in the regeneration of tissue lesions induced by antimetabolite chemotherapy; however, the influence of this class of anti-cancer compounds on the stem cells remains largely unknown. - Methods - The survival of MSCs after exposure to 5-fluorouracil (5-FU) and gemcitabine was measured by viability and clonogenic assays. MSC morphology, surface marker expression, adhesion potential, cellular velocity and differentiation potential were determined after antimetabolite treatment. Cell cycle distribution and apoptosis were assessed using flow cytometry, and senescence induction was evaluated by beta-galactosidase staining. Gene expression arrays were used to analyze the expression of enzymes involved in DNA metabolism and multidrug resistance. - Results - Here, we show that human primary bone marrow MSCs are relatively resistant to treatment with the widely used antimetabolite drugs 5-FU and gemcitabine. The stem cells were able to largely retain their functional abilities and defining stem cell traits after antimetabolite exposure. MSCs surface markers were found stably expressed, and the characteristic multi-lineage differentiation potential was maintained irrespective of 5-FU or gemcitabine treatment. High expression levels of enzymes involved in DNA metabolism and multidrug resistance transporters may contribute to the resistance to antimetabolite chemotherapy. - Discussion - The observed resistance and functional integrity may form the basis for further investigations of MSCs as a potential therapy for antimetabolite-induced tissue damage.
DOI:doi:10.1016/j.scr.2019.101536
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1016/j.scr.2019.101536
 Volltext: http://www.sciencedirect.com/science/article/pii/S1873506119301667
 DOI: https://doi.org/10.1016/j.scr.2019.101536
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Antineoplastic agents
 Fluorouracil
 Gemcitabine
 Mesenchymal stem cells (MSCs)
 Mesenchymal stromal cells (MSCs)
 Neoplasms
 Stem cells
K10plus-PPN:1685122329
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68466586   QR-Code
zum Seitenanfang